Evaluation of exercise capacity with cardiopulmonary exercise testing and BNP levels in adult patients with single or systemic right ventricles

Archives of Medical Science

Volumn 6, Issue 2, 2010, Pages 192-197

  Trojnarska, Olga ^a   Gwizdała, Adrian ^a   Katarzyński, Sławomir ^a   Katarzyńska, Agnieszka ^a   Oko Sarnowska, Zofia ^a   Brȩborowicz, Piotr ^a   Grajek, Stefan ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

B type natriuretic peptide; Common ventricle; Fontan operation; Grown up congenital heart disease; Heart failure; Senning Mustard operation

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE; FEMALE; FONTAN PROCEDURE; FORCED EXPIRATORY VOLUME; GREAT VESSELS TRANSPOSITION; HEART RATE; HEART SINGLE VENTRICLE; HUMAN; MALE; SPIROMETRY;

EID: 77951946381     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2010.13893     Document Type: Article

References (40)

1. Graham TP, Bernard YD, Mellen BG, et al. Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. J Am Coll Cardiol 2000; 36: 255-261
2. Beauchesne LM, Warnes CA, Connolly HM. Outcome of the unoperated adult who present with congenitally corrected transposition of the great arteries. J Am Coll Cardiol 2002; 40: 285-290 (Pubitemid 34756289)
3. Puley G, Siu S, Connolly M, et al. Arrhythmia and survival in patients > 18 years of age after the Mustard procedure for complete transposition of the great arteries. Am J Cardiol 1999; 83: 1080-1086 (Pubitemid 29162795)
4. Ross-Hesselink JW, Meijboom FJ, Spitaels SE, et al. Decline in ventricular function and clinical condition after Mustard repair for transposition of the great arteries (a prospective study of 22-29 years). Eur Heart J 2004; 25: 1264-1270
5. Moons P, Gewlong M, Sluysmans T, et al. Long term outcome up to 30 years after the Mustard or Senning operation: a nationwide multicenter study in Belguim. Heart 2004; 90: 307-313 (Pubitemid 38250728)
6. Gilliam T, Eriksson BP, Sixt R. Cardiac output and pulmonary gas exchange at maximal exercise after atrial redirection for complete transposition of the great arteries. Eur Heart J 1998; 19: 1856-1864 (Pubitemid 28556656)
7. Bolger AP, Gatzoulis MA. Towards defining heart failure in adults with congenital heart disease. Int J Cardiol 2004; 97 (Suppl 1): 15-23. (Pubitemid 39601747)
8. Piran S, Veldtman G, Siu S, Webb GD, Liu PP. Heart failure and ventricular dysfunction in patients with single or systemic right ventricle. Circulation 2002; 105: 1189-1194 (Pubitemid 34225819)
9. Inai K, Nakanishi T, Nakazawa M. Clinical correlation and prognostic predictive value of neurohormonal factors in patients late after the Fontan operation. Am Heart J 2005; 150: 588-594 (Pubitemid 41317635)
10. Dos L, Teruel L, Ferreira IJ, et al. Late outcome after Senning and Mustard procedures for correction of transposition of the great arteries. Heart 2005; 91: 625-656 (Pubitemid 40559361)
11. Dimopoulos K, Diller GP, Piepoli MF, Gatzoulis MA. Exercise intolerance in adults with congenital heart disease. Cardiol Clin 2006; 24: 641-660 (Pubitemid 44717525)
12. Warnes CA. The adults with congenital heart disease. Born to be bad? J Am Coll Cardiol 2005; 46: 1-8.
13. Connelly MS, Liu PP, Williams WG, Webb GD, Robertson P, McLaughlin PR. Congenitally corrected transposition of the great arteries in the adults: functional status and complications. J Am Coll Cardiol 1996; 27: 1238-1243 (Pubitemid 26117719)
14. Ohuchi H, Takasugi H, Ohashi H, et al. Abnormalities of neurohormonal and cardiac autonomic nervous activities relate poorly to functional status in Fontan patients. Circulation 2004; 110: 2601-2608 (Pubitemid 39453009)
15. Fredriksen PM, Veldtman G, Hechter S, et al. Aerobic capacity in adults with various congenital heart disease. Am J Cardiol 2001; 87: 310-314 (Pubitemid 32144872)
16. Trojnarska O, Gwizdala A, Lanocha M, et al. Cardiopulmonary exercise testing in the evaluation of exercise capacity and B-type natriuretic protein level in adult patients after repair of coarctation of aorta. Tex Heart Inst J 2007; 34: 412-419
17. Trojnarska O, Szyszka A, Gwizdala A, et al. Evaluation of exercise capacity with cardiopulmonary exercise testing and with type B natriuretic peptide concentration in adults patients with patent atrial septal defect. Cardiology 2006; 106: 154-162
18. Trojnarska O, Szyszka A, Gwizdala A, et al. The BNP concentration and exercise capacity assessment with cardiopulmonary stress test in patients after surgical repair of Fallot's tetralogy. Int J Cardiol 2006; 110: 86-92. (Pubitemid 43729941)
19. Engelfriet P, Boersma E, Oechslin E, et al. The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 years follow-up period. The Euro Heart Survey on adult congenital heart disease. Eur Heart J 2005; 26: 2325-2333
20. Wedberg K, Cleland J, Dargie H, et al. Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26: 1115-1140
21. Book WM, Hott BJ, McConnel M. B-type natriuretic peptide levels in adults with congenital heart disease and right ventricular failure. Am J Cardiol 2005; 95: 545-546 (Pubitemid 40247563)
22. Glaser S, Opitz CF, Bauer U, et al. Assessment of symptoms and exercise capacity in cyanotic patients with congenital heart disease. Chest 2004; 125: 368-376 (Pubitemid 38223610)
23. Diller GP, Dimopoulos K, Okonko D, et al. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation 2005; 112: 828-835 (Pubitemid 41170068)
24. Giardini A, Lovato L, Donti A, et al. Relation between right ventricular structural alterations and markers of adverse clinical outcome in adults with systemic right ventricle and either congenital complete (after Senning operation) or congenital corrected transposition of the great arteries. Am J Cardiol 2006; 98: 1277-1282 (Pubitemid 44584118)
25. Ohuchi H, Watanabe K, Kishiki K, Wakisako Y, Echigo S. Heart rate dynamics during and after exercise in postoperative congenital heart disease patients. Their relation to cardiac autonomic nervous activity and intrinsic sinus node dysfunction. Am Heart J 2007; 154: 165-171
26. Norozi K, Wessel A, Cand VA, et al. Chronotropic incompetence in adolescents and adults with congenital heart disease after cardiac surgery. J Card Fail 2007; 13: 263-268 (Pubitemid 46756337)
27. Law YM, Keller BB, Feingold BM, Boyle GJ. Usefulness of plasma B-type natriuretic peptide to identify ventricular dysfunction in pediatric and adult patients with congenital heart disease. Am J Cardiol 2005; 95: 474-478 (Pubitemid 40247541)
28. Cowley CG, Bradley JD, Shaddy RE. B-type natriuretic peptide levels in congenital heart disease. Pediatr Cardiol 2004; 25: 336-340 (Pubitemid 38989516)
29. Bolger AP, Sharma R, Lei W, et al. Neurohormonal activation and chronic heart failure syndrome in adults with congenital heart disease. Circulation 2002; 106: 92-99 (Pubitemid 34747447)
30. Dore A, Houde C, Chan KL, et al. Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricle: a multicenter, randomized, placebo-controlled clinical trial. Circulation 2005; 112: 2411-2416 (Pubitemid 41504490)
31. Yap LB. B-type natriuretic peptide and right heart. Heart Fail Rev 2004; 9: 99-103.
32. Oosterhof T, Tulewski II, Vliegen HW, Spijkerboer O, Mudler BJ. Effects of volumeand/or pressure overeload secondary to congenital heart disease (tetralogy of Fallot or pulmonary stenosis) on right ventricular function using cardiovascular magnetic resonance and B-type natriuretic peptide levels. Am J Cardiol 2006; 97: 1051-1055
33. Yap LB, Ashrafian H, Mukerjee D, Coghlan JG, Timms PM. The natriuretic peptides and their role in disorders of right heart dysfunction and pulmonary hypertension. Clin Biochem 2004; 37: 847-856 (Pubitemid 39209023)
34. Cheung EW, Lam WW, Chiu CS, Chau AK, Cheung SC, Cheung Y. Plasma brain natriuretic peptide levels, right ventricular volume overeload and exercise capacity in adolescens after surgical repair of tetralogy of Fallot. Int J Cardiol 2007; 121: 155-162 (Pubitemid 47379452)
35. Trojnarska O, Szyszka A, Gwizdala A, et al. Adults with Ebstein anomaly-cardiopulmonary exercise testing and BNP level. Int J Cardiol 2006; 111: 92-97
36. Giardini A, Scecchia S, Berton E, et al. Strong and independent prognostic value of peak circulatory power in adults with congenital heart disease. Am Heart J 2007; 154: 441-447 (Pubitemid 47268248)
37. Fredriksen PM, Chen A, Veldtman G, Hechter S, Therrien J, Webb G. Exercise capacity in adult patients with congenitally corrected transposition of the great arteries. Heart 2001; 85: 191-195 (Pubitemid 32973592)
38. Diller GP, Dimopoulos K, Okonko D, et al. Heart rate response during exercise predicts survival in adults with congenital heart disease. J Am Coll Cardiol 2006; 48: 1250-1256 (Pubitemid 44345139)
39. Lauer MS, Francis GS, Okin PM, Pashkow FJ, Snader CE, Marvock TH. Impaired chronotropic response to exercise stress test as a prior of mortality. JAMA 1999; 281: 524-529
40. Larsson DA, Meurling CJ, Holmqvist F, Waktare JE, Thilen UJ. The diagnostic and prognostic value of brain natriuretic peptides in adults with a systemic morphologically right ventricle or Fontan-type circulation. Int J Cardiol 2007; 114: 345-351 (Pubitemid 44855914)